Get the Stockscreener App
12.05
0.42%
0.05
Surgery Partners Inc stock is traded at $12.05, with a volume of 944.07K.
It is up +0.42% in the last 24 hours and down -22.21% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$12.00
Open:
$12.11
24h Volume:
944.07K
Relative Volume:
0.58
Market Cap:
$1.56B
Revenue:
$3.31B
Net Income/Loss:
$98.90M
P/E Ratio:
-19.65
EPS:
-0.6131
Net Cash Flow:
$195.60M
1W Performance:
-2.51%
1M Performance:
-22.21%
6M Performance:
-44.19%
1Y Performance:
-50.19%
1-Day Range:
$11.66
$12.17
1-Week Range:
$11.61
$12.46
52-Week Range:
$11.61
$24.60
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
12.05 | 1.56B | 3.31B | 98.90M | 195.60M | -0.6131 |
HCA
Hca Healthcare Inc
|
484.02 | 108.21B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
200.04 | 17.40B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.26 | 12.43B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
203.89 | 11.85B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
186.72 | 11.41B | 17.36B | 1.51B | 849.25M | 23.15 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
Aug PostEarnings: Should value investors consider Surgery Partners Inc2026 Update & Capital Efficiency Focused Ideas - baoquankhu1.vn
A Look At Surgery Partners (SGRY) Valuation After Recent Share Price Weakness - Sahm
Deals tracker: Cencora to buy ophthalmology practice for $1.1B - Modern Healthcare
Quarterly Risk: What are analysts price targets for Surgery Partners Inc2026 Action & Verified Short-Term Plans - baoquankhu1.vn
Published on: 2026-03-23 00:20:23 - baoquankhu1.vn
SGRY SEC FilingsSurgery Partners Inc 10-K, 10-Q, 8-K Forms - Stock Titan
The Technical Signals Behind (SGRY) That Institutions Follow - Stock Traders Daily
Hudson Bay Capital Management LP Sells 133,637 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners stock hits 52-week lowhere's why - MSN
SGRY Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates - GlobeNewswire
Surgery Partners stock hits 52-week low at 12.22 USD By Investing.com - Investing.com South Africa
Surgery Partners Inc (SGRY) Trading Down 2.45% on Mar 18 - GuruFocus
Surgery Partners (NASDAQ:SGRY) Hits New 12-Month LowTime to Sell? - MarketBeat
Surgery Partners stock hits 52-week low at 12.22 USD - Investing.com
Surgery Partners or Tenet Healthcare: Which Stock Has More Upside? - Trefis
Duly Health and Care's Surgical Centers in Lombard and Westmont Named to U.S. News & World Report 2026 Best Ambulatory Surgery Centers List - Yahoo Finance
Surgery Partners outlines $3.35B–$3.45B revenue target for 2026 while advancing portfolio optimization - MSN
SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
Doherty, Surgery Partners CFO, sells $110k in SGRY stock - Investing.com
Surgery Partners appoints Lloyd Dean to board of directors - Investing.com Nigeria
Jennifer Baldock Sells 5,798 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
David Doherty Sells 8,867 Shares of Surgery Partners (NASDAQ:SGRY) Stock - MarketBeat
Surgery Partners (NASDAQ:SGRY) CEO Jason Eric Evans Sells 20,400 Shares - MarketBeat
Surgery Partners (NASDAQ:SGRY) Insider Danielle Burkhalter Sells 3,469 Shares - MarketBeat
Surgery Partners (SGRY) HR chief sells shares to cover taxes - Stock Titan
Surgery Partners (SGRY) strategy chief sells shares to cover tax withholding - Stock Titan
Surgery Partners (SGRY) CFO disposes shares to cover tax withholding - Stock Titan
Surgery Partners (SGRY) CEO sells shares to cover tax on RSU vesting - Stock Titan
[Form 4] Surgery Partners, Inc. Insider Trading Activity - Stock Titan
Insider sale notice: Surgery Partners (NASDAQ: SGRY) to sell 20,400 shares - Stock Titan
Short Interest in Surgery Partners, Inc. (NASDAQ:SGRY) Decreases By 15.7% - MarketBeat
Irenic Capital Management LP Boosts Holdings in Surgery Partners, Inc. $SGRY - MarketBeat
Farallon Capital Management LLC Cuts Stock Position in Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners Inc Stock (ISIN: US85701Q1031) Faces Investor Scrutiny Amid Soft Guidance and Strat - AD HOC NEWS
Surgery Partners (SGRY) Is Down 7.3% After Soft 2026 Outlook, Buyback Launch, and New Director - simplywall.st
8 Knots Management LLC Takes Position in Surgery Partners, Inc. $SGRY - MarketBeat
Activist investor calls for Surgery Partners leadership change By Investing.com - Investing.com Nigeria
Sirios Capital Management L P Buys Shares of 374,948 Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners appoints Lloyd Dean to board of directors By Investing.com - Investing.com Australia
Pier Capital LLC Purchases 154,160 Shares of Surgery Partners, Inc. $SGRY - MarketBeat
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2025 earnings call transcript - MSN
Surgery Partners, Inc. Names Lloyd Dean to Board of Directors - The Manila Times
Surgery Partners, Inc. Appoints Lloyd Dean as Independent Director to Board of Directors - Quiver Quantitative
Surgery Partners (SGRY) Is Down 9.7% After Soft 2026 Outlook And New Buyback PlanHas The Bull Case Changed? - Yahoo Finance
Assessing Surgery Partners (SGRY) Valuation After Activist Pressure And Mixed Earnings Updates - simplywall.st
Surgery Partners (SGRY) Guided for Margin Expansion While Headwinds Mounted -- Levi & Korsinsky, LLP Investigates - GlobeNewswire
Ortelius Targets Surgery Partners Governance While Shares Screen As Undervalued - Yahoo Finance
UBS Maintains Buy on Surgery Partners (SGRY) on March 11, 2026 - Meyka
UBS reiterates Surgery Partners stock rating after activist letter By Investing.com - Investing.com Canada
Surgery Partners at Barclays Healthcare Conference: Strategic Plans Amid Challenges - Investing.com
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):